Back
Globus Medical Quote, Financials, Valuation and Earnings
Sponsored
GMED
Sponsored
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Buy
66
GMED
Globus Medical
Last Price:
62.86
Seasonality Move:
3.48%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).Globus Medical Price Quote
$62.86
+0.02 (+-1.4%)
(Updated: May 15, 2024 at 3:38 AM ET)
Globus Medical Key Stats
Buy
66
Globus Medical (GMED)
is a Buy
Day range:
$62.13 - $64.54
52-week range:
$43.39 - $65.74
Dividend yield:
0%
P/E ratio:
59.58
P/S ratio:
4.12
P/B ratio:
2.2%
Volume:
741.7K
Avg. volume:
1.2M
1-year change:
10.58%
Market cap:
$8.6B
Revenue:
$1.6B
EPS:
$0.64
How Much Does Globus Medical Make?
-
How Much Are Globus Medical's Sales Annually?
GMED Revenues are $1.6B -
How Much Profit Does Globus Medical's Make A Year?
GMED net income is $122.9M
Is Globus Medical Growing As A Company?
-
What Is Globus Medical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.19% -
What Is Globus Medical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Globus Medical Stock Price Performance
-
Did Globus Medical Stock Go Up Last Month?
Globus Medical share price went up by 21.62% last month -
Did GMED's Share Price Rise Over The Last Year?
GMED share price rose by 10.58% over the past 1 year
What Is Globus Medical 52-Week High & Low?
-
What Is Globus Medical’s 52-Week High Share Price?
Globus Medical has traded as high as $65.74 over the past 52 weeks -
What Is Globus Medical’s 52-Week Low Share Price?
Globus Medical has traded as low as $43.39 over the past 52 weeks
Globus Medical Price To Free Cash Flow
-
Is Globus Medical Stock Overvalued?
Globus Medical is trading at a price to free cash flow ratio of 51.52 -
Is Globus Medical Stock Undervalued?
Globus Medical EV to Free Cash Flow ratio is 56.68 -
What Is Globus Medical’s Price Earnings Growth Ratio?
GMED PEG ratio is 0.00 -
Is Globus Medical Trading At A Premium To Earnings?
Globus Medical EV to EBIT ratio is 49.53
Is It Risky To Buy Globus Medical?
-
How Much Debt Does Globus Medical Have?
Total long term debt quarterly is $424M -
How Much Cash Does Globus Medical Have?
Cash and short term investments quarterly total is $434.5M -
What Is Globus Medical’s Book Value Per Share?
Book value per share is 29.04
Is Globus Medical Cash Flow Positive?
-
What Is GMED Cash Flow From Operations?
Cash flow from operations (TTM) is $242.6M -
What Is Globus Medical’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$350.5M -
What Is Globus Medical’s Cash Flow From Investing?
Cash flow from investing (TTM) is $245.4M
Globus Medical Return On Invested Capital
-
Is Management Doing A Good Job?
GMED return on invested capital is 1.93% -
What Is Globus Medical Return On Assets?
ROA measures how assets are converting to revenues and is 1.69% -
What Is GMED Return On Equity?
ROE is a measure of profitability and is 2.08%
Globus Medical Earnings Date & Stock Price
-
What Is Globus Medical's Stock Price Today?
A single share of GMED can be purchased today for 62.84 -
What Is Globus Medical’s Stock Symbol?
Globus Medical trades on the nyse under the ticker symbol: GMED -
When Is Globus Medical’s Next Earnings Date?
The next quarterly earnings date for Globus Medical is scheduled on August 2, 2024 -
When Is GMED's next ex-dividend date?
Globus Medical's next ex-dividend date is May 27, 2020 -
How To Buy Globus Medical Stock?
You can buy Globus Medical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Globus Medical Competitors
-
Who Are Globus Medical's Competitors?
Below is a list of companies who compete with Globus Medical or are related in some way:
Globus Medical Dividend Yield
Data Unavailable
Globus Medical Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 26.98% |
Revenue: | 119.26% | 2.9% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 6 |
Sell Recommendations: | 0 |
Price Target: | 68.75 |
Upside from Last Price: | 9.4% |